Stockreport

Bolt Biotherapeutics Announces Changes to its Board of Directors

Bolt Biotherapeutics, Inc.  (BOLT) 
PDF REDWOOD CITY, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new class of immuno-on [Read more]